Nanoparticles and the cardiovascular system: A critical review

Nanomedicine

Volumn 8, Issue 3, 2013, Pages 403-423

  Donaldson, Ken ^a   Duffin, Rodger ^b   Langrish, Jeremy P ^c   Miller, Mark R ^c   Mills, Nicholas L ^c   Poland, Craig A ^d   Raftis, Jennifer ^a   Shah, Anoop ^c   Shaw, Catherine A ^c   Newby, David E ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CXR Biosciences Ltd   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

Author keywords

atherosclerosis; atherothrombosis; cardiovascular; combustion; engineered; inflammation; lungs; manufactured; nanoparticles

Indexed keywords

CARBON; NANOPARTICLE;

AIR POLLUTION; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; BLOOD; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CEREBROVASCULAR ACCIDENT; COMBUSTION; HEART FAILURE; HUMAN; INFLAMMATION; MICROCIRCULATION; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 84874869202     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.16     Document Type: Review

References (132)

1. Donaldson K, Seaton A. A short history of the toxicology of inhaled particles. Part. Fibre Toxicol. 9, 13 (2012)
2. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 175, 191-199 (2001)
3. Kreyling WG, Moller W, Semmler-Behnke M, Oberdorster G. Particle dosimetry: deposition and clearance from the respiratory tract and translocaton to extra-pulmonary sites. In: Particle Toxicology. Donaldson K, Borm P (Eds). CRC Press, FL, USA, 47-74 (2007)
4. Yu CP, Hu JP. Diffusional deposition of ultrafine particles in the human lung. In: Aerosols in the Mining and Industrial Work Environments. Marple VA, Liu VYH (Eds). Ann Arbor Sciences, MI, USA, 139-149 (1983)
5. Sun JD, Wolff RK, Kanapilly GM, McClellan RO. Lung retention and metabolic fate of inhaled benzo(a)pyrene associated with diesel exhaust particles. Toxicol. Appl. Pharmacol. 73, 48-59 (1984)
6. Lam HF, Conner MW, Rogers AE, Fitzgerald S, Amdur MO. Functional and morphologic changes in the lungs of guinea pigs exposed to freshly generated ultrafine zinc oxide. Toxicol. Appl. Pharmacol. 78, 29-38 (1985)
7. Ferin J, Oberdorster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 6, 535-542 (1992)
8. Brown DM, Stone V, Findlay P, MacNee W, Donaldson K. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup. Environ. Med. 57, 685-691 (2000)
9. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal. Toxicol. 12, 1113-1126 (2000)
10. Donaldson K, Tran L, Jimenez L et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part. Fibre Toxicol. 2, 10 (2005)
11. Stoeger T, Takenaka S, Frankenberger B et al. Deducing in vivo toxicity of combustion-derived nanoparticles from a cell-free oxidative potency assay and metabolic activation of organic compounds. Environ. Health Perspect. 117, 54-60 (2009)
12. Neumann HG. Health risk of combustion products: toxicological considerations. Chemosphere 42, 473-479 (2001)
13. Donaldson K, Mills N, MacNee W, Robinson S, Newby D. Role of inflammation in cardiopulmonary health effects of PM. Toxicol. Appl. Pharmacol. 207, 483-488 (2005)
14. Mills NL, Donaldson K, Hadoke PW et al. Adverse cardiovascular effects of air pollution. Nat. Clin. Pract. Cardiovasc. Med. 6(1), 36-44 (2008)
15. Langrish JP, Mills NL, Newby DE. Air pollution: the new cardiovascular risk factor. Intern. Med. J. 38, 875-878 (2008)
16. Gupta AS. Nanomedicine approaches in vascular disease: a review. Nanomedicine 7, 763-779 (2011)
17. Donaldson K, Seaton A. The Janus faces of nanoparticles. J. Nanosci. Nanotechnol. 7, 4607-4611 (2007)
18. Borm PJ, Muller-Schulte D. Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine (Lond.) 1, 235-249 (2006)
19. Donaldson K. Resolving the nanoparticles paradox. Nanomedicine 1, 229-234 (2006)
20. WHO. Exposure to air pollution:a major public health concern. In: Preventing Disease Through Healthy Environments. WHO, Geneva, Switzerland (2010)
21. Nemery B, Hoet PH, Nemmar A. The Meuse Valley fog of 1930: an air pollution disaster. Lancet 357, 704-708 (2001)
22. Stone R. Air pollution. Counting the cost of London's killer smog. Science 298, 2106-2107 (2002)
23. Brunekreef B, Holgate ST. Air pollution and health. Lancet 360, 1233-1242 (2002)
24. Miller KA, Siscovick DS, Sheppard L et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N. Engl. J. Med. 356, 447-458 (2007)
25. Dockery DW, Pope CA, Xu XP et al. An association between air-pollution and mortality in six U.S. cities. N. Engl. J. Med. 329(24), 1753-1759 (1993)
26. Pope CA, Thun MJ, Namboodiri MM et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am. J. Respir. Crit. Care Med. 151(3 Pt 1), 669-674 (1995)
27. Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ. Health Perspect. 109(Suppl. 3), 405-409 (2001)
28. Kunzli N, Jerrett M, Mack WJ et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ. Health Perspect. 113, 201-206 (2005)
29. Mustafic H, Jabre P, Caussin C et al. Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA 307, 713-721 (2012)
30. Peters A, von Klot S, Heier M et al. Exposure to traffic and the onset of myocardial infarction. N. Engl. J. Med. 351, 1721-1730 (2004)
31. Nawrot TS, Perez L, Kunzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet 377, 732-740 (2011)
32. Roger VL, Go AS, Lloyd-Jones DM et al. Executive summary: heart disease and stroke statistics -2012 update: a report from the American Heart Association. Circulation 125, 188-197 (2012)
33. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the medicare fee-for-service program. N. Engl. J. Med. 360, 1418-1428 (2009)
34. Dominici F, McDermott A, Zeger SL, Samet JM. On the use of generalized additive models in time-series studies of air pollution and health. Am. J. Epidemiol. 156, 193-203 (2002)
35. Ueda K, Nitta H, Ono M. Effects of fine particulate matter on daily mortality for specific heart diseases in Japan. Circ. J. 73, 1248-1254 (2009)
36. Silverman RA, Ito K, Freese J et al. Association of ambient fine particles with out-of-hospital cardiac arrests in New York City. Am. J. Epidemiol. 172, 917-923 (2010)
37. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 294(10), 1255-1259 (2005)
38. Committee on the Medical Effects of Air Pollutants. Cardiovascular disease and air pollution. 2006. Department of Health, London, UK, 1-215 (2006)
39. Ghio AJ, Huang YC. Exposure to concentrated ambient particles (CAPs): a review. Inhal. Toxicol. 16, 53-59 (2004)
40. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105, 1534-1536 (2002)
41. Urch B, Silverman F, Corey P et al. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ. Health Perspect. 113, 1052-1055 (2005)
42. Brook RD, Urch B, Dvonch JT et al. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension 54, 659-667 (2009)
43. Peretz A, Sullivan JH, Leotta DF et al. Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ. Health Perspect. 116, 937-942 (2008)
44. Lundback M, Mills NL, Lucking A et al. Experimental exposure to diesel exhaust increases arterial stiffness in man. Part. Fibre Toxicol. 6, 7 (2009)
45. Chang LT, Tang CS, Pan YZ, Chan CC. Association of heart rate variability of the elderly with personal exposure to PM 1, PM 1-2.5, and PM 2.5-10. Bull. Environ. Contam. Toxicol. 79, 552-556 (2007)
46. Arito H, Takahashi M, Iwasaki T, Uchiyama I. Age-related changes in ventilatory and heart rate responses to acute ozone exposure in the conscious rat. Ind. Health 35, 78-86 (1997)
47. Park SK, O'neill MS, Vokonas PS, Sparrow D, Schwartz J. Effects of air pollution on heart rate variability: the VA normative aging study. Environ. Health Perspect. 113, 304-309 (2005)
48. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93(5), 1043-1065 (1996)
49. Mills NL, Finlayson AE, Gonzalez MC et al. Diesel exhaust inhalation does not affect heart rhythm or heart rate variability. Heart 97, 544-550 (2011)
50. Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W. Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability. Eur. Respir. J. Suppl. 40, S76-S80 (2003)
51. Routledge HC, Chowdhary S, Townend JN. Heart rate variability -a therapeutic target? J. Clin. Pharm. Ther. 27, 85-92 (2002)
52. de Hartog JJ, Lanki T, Timonen KL et al. Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease. Environ. Health Perspect. 117, 105-111 (2009)
53. Campen MJ, Nolan JP, Schladweiler MC, Kodavanti UP, Costa DL, Watkinson WP. Cardiac and thermoregulatory effects of instilled particulate matter-associated transition metals in healthy and cardiopulmonary-compromised rats. J. Toxicol. Environ. Health A 65, 1615-1631 (2002)
54. Mills NL, Tornqvist H, Gonzalez MC et al. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N. Engl. J. Med. 357, 1075-1082 (2007)
55. Mills NL, Tornqvist H, Robinson SD et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 112, 3930-3936 (2005)
56. Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 105, 452-456 (2002)
57. Langrish JP, Unosson B, Bosson J. Diesel exhaust inhalation induced vascular dysfunction: the role of nitric oxide. Am. J. Resp. Crit. Care Med. 57(14), E1429 (2011)
58. Mills NL, Miller MR, Lucking AJ et al. Combustion-derived nanoparticulate induces the adverse vascular effects of diesel exhaust inhalation. Eur. Heart J. 32, 2660-2671 (2011)
59. Mills NL, Robinson SD, Fokkens PH et al. Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ. Health Perspect. 116, 709-715 (2008)
60. Lucking AJ, Lundback M, Mills NL et al. Diesel exhaust inhalation increases thrombus formation in man. Eur. Heart J. 29, 3043-3051 (2008)
61. Miller MR, Shaw CA, Langrish JP. From particles to patients: oxidative stress and the cardiovascular effects of air pollution. Future Cardiol. 8, 577-602 (2012)
62. Aung HH, Lame MW, Gohil K et al. Comparative gene responses to collected ambient particles in vitro: endothelial responses. Physiol. Genomics 43, 917-929 (2011)
63. Karoly ED, Li Z, Dailey LA, Hyseni X, Huang YC. Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposure. Environ. Health Perspect. 115, 535-540 (2007)
64. Lee CC, Huang SH, Yang YT, Cheng YW, Li CH, Kang JJ. Motorcycle exhaust particles up-regulate expression of vascular adhesion molecule2011;1 and intercellular adhesion molecule2011;1 in human umbilical vein endothelial cells. Toxicol. In Vitro 26, 552-560 (2012)
65. Forchhammer L, Loft S, Roursgaard M et al. Expression of adhesion molecules, monocyte interactions and oxidative stress in human endothelial cells exposed to wood smoke and diesel exhaust particulate matter. Toxicol. Lett. 209, 121-128 (2012)
66. Frikke-Schmidt H, Roursgaard M, Lykkesfeldt J, Loft S, Nojgaard JK, Moller P. Effect of vitamin C and iron chelation on diesel exhaust particle and carbon black induced oxidative damage and cell adhesion molecule expression in human endothelial cells. Toxicol. Lett. 203, 181-189 (2011)
67. Montiel-Davalos A, Alfaro-Moreno E, Lopez-Marure R. PM2.5 and PM10 induce the expression of adhesion molecules and the adhesion of monocytic cells to human umbilical vein endothelial cells. Inhal. Toxicol. 19(Suppl. 1), 91-98 (2007)
68. Li R, Ning Z, Cui J et al. Ultrafine particles from diesel engines induce vascular oxidative stress via JNK activation. Free Radic. Biol. Med. 46, 775-782 (2009)
69. Chao MW, Po IP, Laumbach RJ, Koslosky J, Cooper K, Gordon MK. DEP induction of ROS in capillary-like endothelial tubes leads to VEGF2011;A expression. Toxicology 297, 34-46 (2012)
70. Chao MW, Kozlosky J, Po IP et al. Diesel exhaust particle exposure causes redistribution of endothelial tube VE-cadherin. Toxicology 279, 73-84 (2011)
71. Li R, Ning Z, Cui J, Yu F, Sioutas C, Hsiai T. Diesel exhaust particles modulate vascular endothelial cell permeability: implication of ZO1 expression. Toxicol. Lett. 197, 163-168 (2010)
72. Sumanasekera WK, Ivanova MM, Johnston BJ et al. Rapid effects of diesel exhaust particulate extracts on intracellular signaling in human endothelial cells. Toxicol. Lett. 174, 61-73 (2007)
73. Nemmar A, Hoet PH, Vanquickenborne B et al. Passage of inhaled particles into the blood circulation in humans. Circulation 105, 411-414 (2002)
74. Mills N, Amin N, Robinson S et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am. J. Resp. Crit. Care Med. 173(4), 426-431 (2006)
75. Kreyling WG, Semmler M, Erbe F et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 65, 1513-1530 (2002)
76. Kristovich R, Knight DA, Long JF. Macrophage-mediated endothelial inflammatory responses to airborne particulates: impact of particulate physicochemical properties. Chem. Res. Toxicol. 17, 1303-1312 (2004)
77. Shaw CA, Robertson S, Miller MR et al. Diesel particulate-exposed macrophages cause marked endothelial cell activation. Am. J. Respir. Cell Mol. Biol. 44(6), 840-851 (2010)
78. Weldy CS, Wilkerson HW, Larson TV, Stewart JA, Kavanagh TJ. DIESEL particulate exposed macrophages alter endothelial cell expression of eNOS, iNOS, MCP1, and glutathione synthesis genes. Toxicol. In Vitro 25, 2064-2073 (2011)
79. Channell MM, Paffett ML, Devlin RB, Madden MC, Campen MJ. Circulating factors induce coronary endothelial cell activation following exposure to inhaled diesel exhaust and nitrogen dioxide in humans: evidence from a novel translational in vitro model. Toxicol. Sci. 127, 179-186 (2012)
80. Siegel PD, Saxena RK, Saxena QB et al. Effect of diesel exhaust particulate (DEP) on immune responses: contributions of particulate versus organic soluble components. J. Toxicol. Environ. Health A 67, 221-231 (2004)
81. Yin XJ, Dong CC, Ma JY, Roberts JR, Antonini JM, Ma JK. Suppression of phagocytic and bactericidal functions of rat alveolar macrophages by the organic component of diesel exhaust particles. J. Toxicol. Environ. Health A 70, 820-828 (2007)
82. Li R, Ning Z, Majumdar R et al. Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: implication of chemical components and NF2011;kappaB signaling. Part. Fibre Toxicol. 7, 6 (2010)
83. Moller P, Mikkelsen L, Vesterdal LK et al. Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis. Crit. Rev. Toxicol. 41, 339-368 (2011)
84. Miller MR, Borthwick SJ, Shaw CA et al. Direct impairment of vascular function by diesel exhaust particulate through reduced bioavailability of endothelium-derived nitric oxide induced by superoxide free radicals. Environ. Health Perspect. 117, 611-616 (2009)
85. Quan C, Sun Q, Lippmann M, Chen LC. Comparative effects of inhaled diesel exhaust and ambient fine particles on inflammation, atherosclerosis, and vascular dysfunction. Inhal. Toxicol. 22, 738-753 (2010)
86. Mills N, Miller MR. Particles and the vascular endothelium. In: Cardiovascular Effects of Inhaled Ultrafine and Nanosized Particles. Cassee F, Mills N, Newby D (Eds). J Wiley & Sons Inc, NJ, USA, 379-402 (2011)
87. Araujo JA, Barajas B, Kleinman M et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ. Res. 102, 589-596 (2008)
88. Campen MJ, Lund AK, Knuckles TL et al. Inhaled diesel emissions alter atherosclerotic plaque composition in ApoE(-/-) mice. Toxicol. Appl. Pharmacol. 242, 310-317 (2010)
89. Sun Q, Yue P, Kirk RI et al. Ambient air particulate matter exposure and tissue factor expression in atherosclerosis. Inhal. Toxicol. 20, 127-137 (2008)
90. Ying Z, Kampfrath T, Thurston G et al. Ambient particulates alter vascular function through induction of reactive oxygen and nitrogen species. Toxicol. Sci. 111, 80-88 (2009)
91. Ikeda M, Shitashige M, Yamasaki H, Sagai M, Tomita T. Oxidative modification of low density lipoprotein by diesel exhaust particles. Biol. Pharm. Bull. 18, 866-871 (1995)
92. Gong KW, Zhao W, Li N et al. Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells. Genome Biol. 8, R149 (2007)
93. Sun Q, Wang A, Jin X et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 294, 3003-3010 (2005)
94. Lund AK, Lucero J, Lucas S et al. Vehicular emissions induce vascular MMP2011;9 expression and activity associated with endothelin2011;1-mediated pathways. Arterioscler. Thromb. Vasc. Biol. 29, 511-517 (2009)
95. Ying Z, Yue P, Xu X et al. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am. J. Physiol. Heart Circ. Physiol. 296, H1540-H1550 (2009)
96. Cozzi E, Hazarika S, Stallings HW 3rd et al. Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice. Am. J. Physiol. Heart Circ. Physiol. 291, H894-H903 (2006)
97. Yan YH, Chou CC, Lee CT, Liu JY, Cheng TJ. Enhanced insulin resistance in diet-induced obese rats exposed to fine particles by instillation. Inhal. Toxicol. 23, 507-519 (2011)
98. Emmerechts J, Alfaro-Moreno E, Vanaudenaerde BM, Nemery B, Hoylaerts MF. Short-term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice. J. Thromb. Haemost. 8, 2651-2661 (2010)
99. Emmerechts J, Hoylaerts MF. The effect of air pollution on haemostasis. Hamostaseologie 32, 5-13 (2012)
100. Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am. J. Respir. Crit. Care Med. 168, 1366-1372 (2003)
101. Nemmar A, Zia S, Subramaniyan D, Fahim MA, Ali BH. Exacerbation of thrombotic events by diesel exhaust particle in mouse model of hypertension. Toxicology 285, 39-45 (2011)
102. Radomski A, Jurasz P, Alonso-Escolano D et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 146, 882-893 (2005)
103. Schulte PA, Trout DB. Nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research. J. Occup. Environ. Med. 53, S3-S7 (2011)
104. Kang GS, Gillespie PA, Gunnison A, Moreira AL, Tchou-Wong KM, Chen LC. Long-term inhalation exposure to nickel nanoparticles exacerbated atherosclerosis in a susceptible mouse model. Environ. Health Perspect. 119, 176-181 (2011)
105. Vesterdal LK, Folkmann JK, Jacobsen NR et al. Pulmonary exposure to carbon black nanoparticles and vascular effects. Part. Fibre Toxicol. 7, 33 (2010)
106. Mikkelsen L, Sheykhzade M, Jensen KA et al. Modest effect on plaque progression and vasodilatory function in atherosclerosis-prone mice exposed to nanosized TiO(2). Part. Fibre Toxicol. 8, 32 (2011)
107. Li Z, Hulderman T, Salmen R et al. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ. Health Perspect. 115, 377-382 (2007)
108. LeBlanc AJ, Cumpston JL, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J. Toxicol. Environ. Health A 72, 1576-1584 (2009)
109. Khandoga A, Stampfl A, Takenaka S et al. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation 109, 1320-1325 (2004)
110. McGuinnes C, Duffin R, Brown S et al. Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro. Toxicol. Sci. 119, 359-368 (2011)
111. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. Int. J. Nanomedicine 7, 631-639 (2012)
112. Burke AR, Singh RN, Carroll DL et al. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials 32, 5970-5978 (2011)
113. Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Gracio JJ, Dash D. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano 6, 2731-2740 (2012)
114. Erdely A, Hulderman T, Salmen R et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 9, 36-43 (2009)
115. Pai AB, Nielsen JC, Kausz A, Miller P, Owen JS. Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects. Clin. Pharmacol. Ther. 88, 237-242 (2010)
116. Richards JM, Semple SI, Macgillivray TJ et al. Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ. Cardiovasc. Imaging 4, 274-281 (2011)
117. Wang H, Zhao Y, Wu Y et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32, 8281-8290 (2011)
118. Yilmaz A, Rosch S, Klingel K et al. Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction -preliminary results. Int. J. Cardiol. doi:10.1016/j.ijcard.2011.06.004 (2011) (Epub ahead of print)
119. Hamzah J, Kotamraju VR, Seo JW et al. Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc. Natl Acad. Sci. USA 108, 7154-7159 (2011)
120. Rosner MH, Auerbach M. Ferumoxytol for the treatment of iron deficiency. Expert Rev. Hematol. 4, 399-406 (2011)
121. Zhu MT, Wang Y, Feng WY et al. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. J. Nanosci. Nanotechnol. 10, 8584-8590 (2010)
122. Zhu MT, Wang B, Wang Y et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol. Lett. 203, 162-171 (2011)
123. Lu S, Duffin R, Poland C et al. Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ. Health Perspect. 117, 241-247 (2009)
124. Dick CA, Brown DM, Donaldson K, Stone V. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal. Toxicol. 15, 39-52 (2003)
125. Jendelova P, Herynek V, Urdzikova L et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 76, 232-243 (2004)
126. Jing XH, Yang L, Duan XJ et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 75, 432-438 (2008)
127. Seaton A, MacNee W, Donaldson K, Godden D. Particulate air-pollution and acute health-effects. Lancet 345, 176-178 (1995)
128. Van ES, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am. J. Respir. Crit. Care Med. 186, 11-16 (2012)
129. Hubbs AF, Mercer RR, Benkovic SA et al. Nanotoxicology -a pathologist's perspective. Toxicol. Pathol. 39, 301-324 (2011)
130. Geiser M, Rothen-Rutishauser B, Kapp N et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 113, 1555-1560 (2005)
131. Oberdorster G, Sharp Z, Elder AP, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16, 437-445 (2004)
132. Moller W, Kreyling WG, Schmid O, Semmler-Behnke M, Schulz H. Deposition, retention and clearance and translocation of inhaled fine and nano-sized particles in the respiratory tract. In: Particle-Lung Cell Interactions (2nd Edition). Gehr P, Muhlfeld C, Rothen-Rutishauser B, Blank F (Eds). Informa Healthcare, NY, USA, 79-107 (2010)